Lifecore Biomedical, Inc. (LFCR)

6.28 -0.29 (-4.41%) 收市：04:00PM EDT

Lifecore Biomedical, Inc.

3515 Lyman Boulevard
Chaska, MN 55318
United States
952 368 4300
https://www.lifecore.com

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 459

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. James G. Hall	CEO, President & Director	523.6k	無	1963
Mr. John D. Morberg	Executive VP & CFO	520.82k	無	1964
Dr. Albert D. Bolles Ph.D.	President of Curation Foods, Inc.	1.34M	無	1958
Mr. Steve W. Laninga	Vice President of Operations	無	無	無
Dr. Kipling Thacker Ph.D.	VP & Chief Scientist	無	無	1955
Mr. Aaron Perlitsh	Director of Internal Audit & Chief Compliance Officer	無	無	無
Mr. Darren M. Hieber	Senior Vice President of Corporate Development & Partnerships	無	無	無
Ms. Kara Morley	Senior Vice President of Human Resources	無	無	無
Ms. Jackie Q. Klecker	Executive VP & GM	無	無	無
Mr. Matt Augustson	Senior Vice President of Information Technology	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

公司管治

截至 2024年5月1日 止，Lifecore Biomedical, Inc. 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中：10；董事會：4；股東權利：1；現金賠償：6。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。